Does ORELABRUTINIB Cause Disease progression? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Disease progression have been filed in association with ORELABRUTINIB. This represents 10.7% of all adverse event reports for ORELABRUTINIB.
14
Reports of Disease progression with ORELABRUTINIB
10.7%
of all ORELABRUTINIB reports
3
Deaths
0
Hospitalizations
How Dangerous Is Disease progression From ORELABRUTINIB?
Of the 14 reports, 3 (21.4%) resulted in death.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ORELABRUTINIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ORELABRUTINIB Cause?
Anaemia (54)
Hypokalaemia (40)
Pneumonia (35)
Neutropenia (30)
Thrombocytopenia (26)
Covid-19 (11)
Platelet count decreased (11)
Drug ineffective (10)
Myelosuppression (10)
Product use in unapproved indication (8)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ORELABRUTINIB Alternatives Have Lower Disease progression Risk?
ORELABRUTINIB vs ORENCIA
ORELABRUTINIB vs ORITAVANCIN
ORELABRUTINIB vs ORITAVANCIN DIPHOSPHATE
ORELABRUTINIB vs ORLISTAT
ORELABRUTINIB vs ORNIDAZOLE